Meneldor Overview
Meneldor offers investors the opportunity to co-invest alongside specialists in early-stage biotech and pharmaceutical companies, focusing on those developing new biological or chemical molecular entities with strong intellectual property, addressing significant unmet medical needs, and targeting attractive markets. The firm primarily invests in projects at preclinical, Phase I, or Phase II stages, with a geographic focus on Western Europe.
Is Meneldor the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Meneldor, along with a list of other relevant VCs, is available on Hopohopo.io.
Meneldor
Investment focus
Invest in
- Western Europe
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- PharmaTech
Investment role
Lead and follow
Stages
Pre-seed, Seed, Series A
First ticket size
€3,000,000 - €3,000,000
Contact information
Founding Partner
Frans Dalen
Founding Partner
Paul Lelieveld
Project & business development manager Pharmaceutical development
Pola Verschoor
How to approach funds like Meneldor
When approaching Meneldor, emphasize the scientific rigor and innovation of your biotech or pharmaceutical project. Highlight strong intellectual property, clear clinical endpoints, and a well-defined path through preclinical to Phase II stages. Demonstrating a significant unmet medical need and an attractive market potential will align with their investment focus.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
